These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1031 related items for PubMed ID: 21967214

  • 1. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S, Yang Y, Liu X, Huang W, Zhang X, Yang S, Zhang X.
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [Abstract] [Full Text] [Related]

  • 2. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 3. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X.
    J Ethnopharmacol; 2008 Jul 23; 118(2):264-70. PubMed ID: 18502066
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X, Roberts MS.
    Br J Dermatol; 2010 Mar 23; 162(3):538-46. PubMed ID: 19772524
    [Abstract] [Full Text] [Related]

  • 5. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep 23; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 6. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A, Wu C, Jiang Y, Wang J, Wu J, Yang X, Yang Y.
    J Ethnopharmacol; 2015 Jul 01; 169():219-28. PubMed ID: 25934513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
    Liu JQ, Hu DH, Zhang ZF, Guan H, She T, Zhang J, Bai XZ.
    Zhonghua Shao Shang Za Zhi; 2009 Dec 01; 25(6):454-9. PubMed ID: 20193171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Fan DL, Zhao WJ, Wang YX, Han SY, Guo S.
    Int J Dermatol; 2012 Apr 01; 51(4):463-72. PubMed ID: 22435440
    [Abstract] [Full Text] [Related]

  • 13. DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway.
    Li Y, Liu H, Liang Y, Peng P, Ma X, Zhang X.
    Biomed Pharmacother; 2017 Jul 01; 91():174-180. PubMed ID: 28458155
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH, Kim YM, Kim BS, Kim JH, Kim MB, Ko HC.
    Wound Repair Regen; 2014 Jul 01; 22(1):125-33. PubMed ID: 24471776
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
    Cho JW, Il KJ, Lee KS.
    Int J Mol Med; 2013 May 01; 31(5):1148-52. PubMed ID: 23503720
    [Abstract] [Full Text] [Related]

  • 16. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
    Tsujita-Kyutoku M, Uehara N, Matsuoka Y, Kyutoku S, Ogawa Y, Tsubura A.
    In Vivo; 2005 May 01; 19(6):959-63. PubMed ID: 16277007
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.